The interrelationship between FGF23 and inflammation opens new research pathways regarding the development and progression of atherosclerosis in subjects with CKD, with translational clinical applicability from diagnostic, prognostic, and therapeutic perspectives focused on modulating FGF23. The gene discussed is FGF23; the disease is chronic kidney disease.